The Potential Role of Sildenafil in Cancer Management through EPR Augmentation
Enhanced permeation retention (EPR) was a significant milestone discovery by Maeda et al. paving the path for the emerging field of nanomedicine to become a powerful tool in the fight against cancer. Sildenafil is a potent inhibitor of phosphodiesterase 5 (PDE-5) used for the treatment of erectile d...
Main Authors: | Mohamed Haider, Amr Elsherbeny, Valeria Pittalà, Antonino N. Fallica, Maha Ali Alghamdi, Khaled Greish |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/6/585 |
Similar Items
-
Sildenafil in Infants and Children
by: Larisa Simonca, et al.
Published: (2017-07-01) -
Clinical deterioration after sildenafil cessation in patients with pulmonary hypertension
by: Anne M Keogh, et al.
Published: (2008-10-01) -
Prolonged priapism following single dose administration of sildenafil: A rare case report
by: Sharma Sachit, et al.
Published: (2009-01-01) -
New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil
by: Marian Cruz-Burgos, et al.
Published: (2021-02-01) -
The first Russian experience of sildenafil application in patients with idiopathic pulmonary hypertension
by: Z Kh Dadacheva, et al.
Published: (2015-09-01)